Skip to main content
Terug
MANE logo

Veradermics, Incorporated

Datakwaliteit: 100%
Overbought
MANE
NYSE Healthcare Biotechnology
€ 61,92
▲ € 3,03 (5,15%)
Marktkapitalisatie: 2,17B
Dagbereik
€ 58,96 € 62,86
52-Weeksbereik
€ 32,00 € 63,03
Volume
158.222
50D / 200D Gem.
€ 47,48 / € 47,48
Vorige Slotkoers
€ 58,89

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (626 peers)

Metriek Aandeel Sector Mediaan
P/E -82,0 0,4
P/B 39,7 2,9
ROE % -76,5 3,7
Net Margin % 3,8
Rev Growth 5Y % 10,0
D/E 0,0 0,2

Belangrijkste Punten

Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -23,69M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-76,46%
ROIC-36,74%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
0,00
Current Ratio11,77
Interest Coverage-45,77

Waardering

P/E Ratio
-82,00
P/B Ratio39,73
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -26,49M
ROE -76,46% ROA -44,61%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -23,69M
ROIC -36,74% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,00 Current Ratio 11,77
Interest Coverage -45,77 Dividend Yield 0,00%
Valuation
P/E Ratio -82,00 P/B Ratio 39,73
P/S Ratio N/A PEG Ratio -4,04
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 2,17B Enterprise Value 2,12B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023
Revenue 0,0 0,0
Net Income -26,49M -16,49M
EPS (Diluted) -0,14 -0,08
Gross Profit 0,0 0,0
Operating Income -26,78M -17,32M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023
Total Assets 59,38M 18,46M
Total Liabilities 4,72M 3,84M
Shareholders' Equity 54,67M 14,62M
Total Debt 0,0 786.000,0
Cash & Equivalents 53,08M 16,30M
Current Assets 55,54M 17,56M
Current Liabilities 4,72M 3,05M